BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 9862741)

  • 21. Cyclosporine-induced syngeneic graft-vs-host disease: prevention of autoaggression by treatment with monoclonal antibodies to T lymphocyte cell surface determinants and to MHC class II antigens.
    Hess AD; Horwitz LR; Laulis MK; Fuchs E
    Clin Immunol Immunopathol; 1993 Dec; 69(3):341-50. PubMed ID: 7694818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conservation of T cell receptor usage by HLA B27-restricted influenza-specific cytotoxic T lymphocytes suggests a general pattern for antigen-specific major histocompatibility complex class I-restricted responses.
    Bowness P; Moss PA; Rowland-Jones S; Bell JI; McMichael AJ
    Eur J Immunol; 1993 Jul; 23(7):1417-21. PubMed ID: 8391985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of peripheral autoregulatory mechanisms that prevent development of cyclosporin-induced syngeneic graft-versus-host disease.
    Hess AD; Fischer AC; Horwitz L; Bright EC; Laulis MK
    J Immunol; 1994 Jul; 153(1):400-11. PubMed ID: 8207251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MHC control of the naive TCR alpha-chain repertoire.
    Merkenschlager M; Benoist C; Mathis D
    J Immunol; 1994 Oct; 153(7):3005-13. PubMed ID: 8089483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunodominance correlates with T-cell receptor (alpha beta) gene usage in the class II-restricted response to influenza haemagglutinin.
    Smith CA; Graham CM; Thomas DB
    Immunology; 1994 Jul; 82(3):343-50. PubMed ID: 7959866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporine-induced autologous graft versus host disease: assessment of cytolytic effector mechanisms and the V beta T-cell receptor repertoire.
    Ruvolo P; Bright E; Kennedy MJ; Morris L; Fischer A; Vogelsang G; Jones R; Hess A
    Transplant Proc; 1995 Feb; 27(1):1363-5. PubMed ID: 7878913
    [No Abstract]   [Full Text] [Related]  

  • 28. Host resistance to cyclosporine induced syngeneic graft-versus-host disease. Requirement for two distinct lymphocyte subsets.
    Fischer AC; Laulis MK; Horwitz L; Beschorner WE; Hess A
    J Immunol; 1989 Aug; 143(3):827-32. PubMed ID: 2526175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermediate TCR cells with self-reactive clones are effector cells which induce syngeneic graft-versus-host disease in mice.
    Osman Y; Watanabe T; Kawachi Y; Sato K; Ohtsuka K; Watanabe H; Hashimoto S; Moriyama Y; Shibata A; Abo T
    Cell Immunol; 1995 Dec; 166(2):172-86. PubMed ID: 7497519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution of responding CD4+ and CD8+ T-cell repertoires during the development of graft-versus-host disease directed to minor histocompatibility antigens.
    Friedman TM; Jones SC; Statton D; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2004 Apr; 10(4):224-35. PubMed ID: 15077221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The orientation and nature of the interaction between beef insulin-specific TCRs and the insulin/class II MHC complex.
    Wither JE; Vukusic B
    J Immunol; 1999 Feb; 162(4):2113-22. PubMed ID: 9973485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporine preferentially inhibits clonal deletion of CD8-positive T cells with an MHC class II restricted autoreactive T-cell receptor.
    Severino ME; Laulis MK; Horwitz LR; Hess AD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):520-3. PubMed ID: 8438399
    [No Abstract]   [Full Text] [Related]  

  • 33. Diverse fine specificity and receptor repertoire of T cells reactive to the major VP1 epitope (VP1230-250) of Theiler's virus: V beta restriction correlates with T cell recognition of the c-terminal residue.
    Kim BS; Bahk YY; Kang HK; Yauch RL; Kang JA; Park MJ; Ponzio NM
    J Immunol; 1999 Jun; 162(12):7049-57. PubMed ID: 10358147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection for amino acid sequence and J beta element usage in the beta chain of DBA/2V beta b- and DBA/2V beta a-derived myoglobin-specific T cell clones.
    Ruberti G; Paragas V; Kim D; Fathman CG
    J Immunol; 1993 Dec; 151(11):6185-94. PubMed ID: 8245460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T cell receptor alpha-chain repertoire of pathogenic autoantibody-inducing T cells in lupus mice.
    Mao C; Osman GE; Adams S; Datta SK
    J Immunol; 1994 Feb; 152(3):1462-70. PubMed ID: 8301146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intermediate TCR cells can induce graft-versus-host disease after allogeneic bone marrow transplantation.
    Weerasinghe A; Kawamura T; Moroda T; Seki S; Watanabe H; Abo T
    Cell Immunol; 1998 Apr; 185(1):14-29. PubMed ID: 9636679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The N-terminal flanking region of the invariant chain peptide augments the immunogenicity of a cryptic "self" epitope from a tumor-associated antigen.
    Hess AD; Thoburn C; Chen W; Miura Y; Van der Wall E
    Clin Immunol; 2001 Oct; 101(1):67-76. PubMed ID: 11580228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autologous graft-vs-host disease: mechanisms and potential therapeutic effect.
    Hess AD; Jones RC; Santos GW
    Bone Marrow Transplant; 1993; 12 Suppl 3():S65-9. PubMed ID: 8124261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reciprocal expression in CD4 or CD8 subsets of different members of the V alpha 11 gene family correlates with sequence polymorphism.
    Sim BC; Gascoigne NR
    J Immunol; 1999 Mar; 162(6):3153-9. PubMed ID: 10092765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of autoimmune disease in mice by germline alteration of the T cell receptor gene expression.
    Sakaguchi S; Ermak TH; Toda M; Berg LJ; Ho W; Fazekas de St Groth B; Peterson PA; Sakaguchi N; Davis MM
    J Immunol; 1994 Feb; 152(3):1471-84. PubMed ID: 7905503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.